| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Andrology (F.H.P., J.T.M.V., R.F.A.W.), Endocrinology and Reproduction (F.H.P., J.T.M.V., R.F.A.W., F.H.d.J.), Epidemiology and Biostatistics (T.S.), Internal Medicine III (F.H.d.J.) and Medical Informatics (F.H.P.), Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
Address all correspondence and requests for reprints to: Frank Pierik, Department of Andrology, University Hospital Dijkzigt Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. E-mail: pierik{at}mi.fgg.eur.nl
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Serum inhibin B levels were closely correlated with the serum FSH levels (r = -0.78, P < 0.001), confirming the role of inhibin B as feedback signal for FSH production.
The spermatogenic function of the testis was evaluated by determining testicular volume and total sperm count. Inhibin B levels were significantly correlated with the total sperm count and testicular volume (r = 0.54 and r = 0.63, respectively; P < 0.001).
Testicular biopsies were obtained in 22 of these men. Inhibin B was significantly correlated with the biopsy score (r = 0.76, P < 0.001). Receiver operating characteristic analysis revealed a diagnostic accuracy of 95% for differentiating competent from impaired spermatogenesis for inhibin B, whereas for FSH, a value of 80% was found.
We conclude that inhibin B is the best available endocrine marker of spermatogenesis in subfertile men.
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
This discrepancy can now be explained on the basis of the aspecificity
of the inhibin assay that was used. Inhibin is a dimer of an 
- and a
ß-subunit. Depending on the type of ß-subunit, (ßA or
ßB), inhibin A or inhibin B is formed. The antibodies
used in the heterologous inhibin RIA were directed against the
-subunit, and they detected both dimeric inhibin and biologically
inactive monomeric -subunits (8). Since new specific sandwich assays
for inhibin A, inhibin B, and uncombined -subunits have been
developed, studies have been undertaken to investigate the role of
inhibins in male and female endocrinology.
One major finding is that inhibin B is the physiologically important form of inhibin in the male, serum inhibin A levels being undetectable (9). The finding that castration results in undetectable inhibin B levels indicates that circulating inhibin B is produced by the testes (10). Furthermore, recent papers have reported a strong negative correlation between FSH and inhibin B in fertile and subfertile men (9, 11, 12, 13, 14).
Little information is available on the correlation of inhibin B with the severity of spermatogenic defects in subfertile men. So far, lower inhibin B levels were reported in a limited number of subfertile men, compared with fertile controls (10). More recently, inhibin B was found to be correlated with the sperm concentration in a study of 349 normal men (12) and in a mixed group of 65 men with normal and impaired spermatogenesis (13).
The aim of this study was to further investigate the clinical value of inhibin B estimations in subfertile men and to correlate inhibin B levels with clinical history, testicular volume, testicular biopsy score, and sperm characteristics. Subsequently, we analyzed the additional value of inhibin B, compared with that of FSH, with special emphasis on the differentiation between normal and impaired spermatogenesis.
|
Subjects and Methods |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
The study comprised 218 consecutive patients that were referred to our andrology outpatient clinic with fertility problems (age, 21–57 yr). In the period September 1996 until October 1997, 235 new patients were enrolled, of which 17 were excluded from further study on the basis of medication (n = 7; androgens or anti-estrogens), unilateral castration (n = 4), hypogonadotropic hypogonadism (n = 3), systemic disease (n = 1; renal failure), or chromosome translocation (n = 2).
Infertility of the couple was defined as a duration of infertility of
more than 1 yr. Patients were subjected to a thorough clinical
evaluation according to the WHO Manual for the Standardized
Investigation and Diagnosis of the Infertile Couple (15). Patients were
diagnosed with normospermia (n = 49; 
20 million sperm/mL),
idiopathic moderate oligozoospermia (n = 69; 5–20 million
sperm/mL), idiopathic severe oligozoospermia (n = 58; >0 and <5
million sperm/mL), idiopathic azoospermia (n = 15), obstructive
azoospermia (n = 6, normal FSH, normal testicular size, and
Johnsen score > 8; in 3 of these men, congenital absence of the
vas deferens was diagnosed with ultrasonography), history of
cryptorchidism (n = 17, accompanied by oligozoospermia), or
Klinefelter’s syndrome (n = 4).
Hormone analyses
Serum samples were stored for a period of 1 day to maximal 5 weeks at -20 C before analysis. Inhibin B was measured using kits purchased from Serotec Limited, Oxford, UK (16). The within-assay coefficient of variance (CV) was less than 9%, and the between-assay CV was less than 15%. The lowest detectable inhibin B concentration was 5 pg/mL (based on the mean value of the blanks + 2 SD). A value of 2.5 pg/mL (the mean of the undetectable range) was assigned to test results below 5 pg/mL. Serum FSH and LH were determined with the Amerlite FSH and LH assays (Orange-Clinical Diagnostics, Amersham, UK). Within-assay and between-assay CVs are less than 3, less than 8% and less than 5, less than 15% for FSH and LH, respectively. Total serum testosterone was determined by RIA, as described earlier (17) (within- and between-assay CV: less than 6 and less than 9%). Using the above assays, mean (SD) FSH, LH, and testosterone levels in a group of normal men were 2.5 (1.3) IU/L, 3.6 (1.9) IU/L, and 17.6 (6.8) nmol/L (18). Per patient, all hormone concentrations were analyzed in the same blood sample.
Semen analysis
Semen analyses were carried out according to the WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction (19). Per patient, the results of the two semen analyses that were performed closest in time to the hormone analyses were selected. Per patient, the average sperm count was calculated. The median time difference (semen analysis date - blood sampling date) was 22 days (10th and 90th percentiles: -23, 51.4 days). Semen samples were obtained and assessed in 205 of the 218 patients.
Testicular evaluation
Testicular volume was estimated with the Prader orchidometer.
Bilateral biopsy specimens were available on 22 of the 218 patients.
Testicular biopsies were performed to discriminate impaired
spermatogenesis from excurrent duct obstruction as a cause for
azoospermia or severe oligozoospermia. Criteria for testicular biopsy
were: azoospermia accompanied by a normal FSH level, or less than 5
million sperm/mL ejaculate. Biopsy specimens were scored using the
method described by Johnsen (20), as modified by Aafjes et
al. (21). Seminiferous tubule cross-sections were rated with a
score from 1 to 10, based on the most advanced stage of spermatogenesis
observed. The mean score of at least 50 tubules was calculated per
biopsy, both for the left and right testis. Tubules scored 10 for
complete and abundant spermatogenesis with at least 5 condensed
spermatids; 8 when all stages of spermatogenesis were present, but less
than 5 condensed spermatids were seen; 7 when no condensed spermatids,
but at least 5 round spermatids were present; 6 when no condensed
spermatids, and less than 5 round spermatids present; 5 when no
spermatids, but 5 or more spermatocytes present; 4 when no spermatids
and less than 5 spermatocytes were present; 3 only spermatogonia
present; 2 for Sertoli cells only; and 1 for no cells in the tubular
section. It was previously shown that spontaneous pregnancy is possible
when a biopsy score of 8 is present, but highly unlikely below a
Johnsen score of 8 (21).
Statistical analysis
The FSH, LH, testosterone, and sperm count variables were transformed logarithmically to achieve a normal distribution. Correlations were calculated with Pearson’s method. Differences between patient groups were tested with one-way ANOVA, followed by Fisher’s least-significant difference method for pairwise comparisons.
The performance of inhibin B or FSH estimations in discriminating
between normal and impaired spermatogenesis (Johnsen score 8 or
<8) was described by receiver operating characteristic (ROC)
statistics. ROC curves were drawn by plotting the sensitivity against
the false positive rate (1-specificity) for varying cutoff levels of
inhibin B and FSH. A nondiscriminating test would follow the diagonal
line of the figure, whereas a 100% accurate so-called gold standard
test would coincide with the upper left corner of the box. By comparing
the areas under the curve (AUCs) for inhibin B and FSH, the diagnostic
values of both hormones were compared (22). AUCs were estimated with
the Wilcoxon statistic (23).
Independent variables predictive of the biopsy score were identified with linear multiple regression analysis. Two-sided P values less than 0.05 were considered significant. Statistical analyses were carried out with the SPSS 7.5 for Windows statistical software package.
|
Results |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
). Compared with the group with
normospermia, the mean serum inhibin B levels were significantly lower
in the groups with severe oligozoospermia, idiopathic azoospermia,
Klinefelter’s syndrome, and a history of cryptorchidism. The mean
inhibin B level in patients with obstructive azoospermia, in which
spermatogenesis may be normal, was significantly higher, when compared
with the other groups.
|
shows the correlations of inhibin
B with parameters related to spermatogenesis. The inhibin B levels were
correlated with the total sperm count (r = 0.54, P
< 0.001; Fig. 2); patients with
obstructive azoospermia were excluded from this correlation and other
correlations with the sperm count. The inhibin B levels were also
significantly correlated with the total bilateral testicular volume
(Fig. 3), the Johnsen score (Fig. 4), and negatively with serum FSH (Fig. 5) and LH levels. The correlation of
inhibin B with LH was not significant if it was adjusted for the FSH
level (r = 0.03, P = 0.63), with which LH is
closely correlated.
|
|
|
|
|
8)
from impaired spermatogenesis (Johnsen score <8), on the basis of
inhibin B and FSH levels, was estimated from the area under the ROC
curve (Fig. 6). The AUC was 0.95
(SE: 0.07) for inhibin B and 0.80 (SE: 0.12)
for FSH. The areas under the ROC curves for inhibin B and FSH were
statistically different (P = 0.04). Depending on the
desired sensitivity or specificity of inhibin B or FSH, a cutoff level
can be deduced from the ROC curves. When the point on the curve closest
to the upper left corner of the box corresponding to 100% sensitivity
and 0% false positives (100% specificity) was selected, this resulted
in cutoff levels of inhibin B less than 139 pg/mL and FSH more than 4.9
IU/L to identify patients with impaired spermatogenesis. The
sensitivity and specificity corresponding to these cutoffs were 83 and
90% for inhibin B, and 75 and 80% for and FSH, respectively.
|
. Sperm count was
not entered as an independent variable, because an unrevealed (partial)
obstruction may bias the biopsy score vs. sperm count
correlation. The regression procedure indicated inhibin B as the best
predictor of the Johnsen score, explaining 58% of the variance. In the
resulting regression equation [Johnsen score = 4.78 + (0.017
x inhibin B) + (0.05 x FSH)], the coefficient for inhibin B was
statistically significant (P = 0.007), whereas FSH did
not improve the regression model (P = 0.24). |
Discussion |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
We now provide further evidence for the value of inhibin B as a marker of spermatogenesis by the novel finding of a statistically significant positive correlation with the most accurate assessment of spermatogenesis in our setting, the testicular biopsy score. We compared the accuracy of FSH and inhibin B levels to distinguish between patients with competent and impaired spermatogenesis, based on the Johnsen score. The area under the ROC curve, corresponding to the accuracy of the diagnostic method, was significantly larger for inhibin B. Multiple linear regression analysis also revealed that FSH had no significant additional predictive value for the Johnsen score above inhibin B.
The choice for a cutoff level for inhibin B or FSH to discriminate competent from impaired spermatogenesis depends on the priority of a high sensitivity or specificity. We arbitrarily chose the cutoff level closest to the upper left corner of the box. The resulting cutoff levels for inhibin B (<139 pg/mL) and FSH (>4.9 IU/L) were surprisingly close to the cutoff levels for these hormones based on control populations. A lower normal limit for inhibin B has not been defined, but it was 140.6 pg/mL (95% confidence interval, 140.6–225.7) for a group of 18 semen donors (9). We use 5.1 IU/L as the upper normal limit for FSH based on the mean plus 2 SD [2.5 + (2 x 1.3)] in a population of normal men (17).
The present data show significant differences in mean inhibin B levels between diagnostic subgroups. The inhibin B levels were significantly lower in patients with a spermatogenic defect, as compared with the group with normospermia. Patients with obstruction as the sole identified cause for azoospermia had normal inhibin B levels, which were significantly higher, compared with other subgroups. With the aspecific heterologous assay for inhibin, no differences in inhibin levels between comparable subgroups were found (7).
A further advantage of inhibin B measurement is that it reflects the function of the total testicular tissue, whereas a biopsy may not be representative for the entire testis. Multiple biopsies, which are nowadays performed for testicular sperm extraction, often show a large variation in the completeness of spermatogenesis (24). This heterogeneity of spermatogenesis is even more conspicuous in patients with impaired spermatogenesis, where sections with complete spermatogenesis may be found among others with germinal cell aplasia, referred to as focal spermatogenesis (25). It has to be established whether inhibin B levels can demonstrate the presence of focal spermatogenesis and, in this way, could reduce the need for invasive testicular biopsies. It is not unlikely that, in many cases, the area of spermatogenesis is too small to substantially increase serum inhibin B levels.
FSH was regarded the most important endocrine marker for testicular function until now (26). The diagnostic value of inhibin B for spermatogenetic disorders seems to be better. This may be explained by the fact that inhibin is a direct product of the seminiferous tubules, and that its secretion is stimulated by the presence of advanced stages of spermatogenesis (27). In contrast, FSH levels are also affected by GnRH, estradiol, and testosterone.
In conclusion, we have confirmed the role of inhibin B in FSH regulation, and we have found a strong correlation of inhibin B levels with spermatogenesis. Our results provide further and novel evidence that inhibin B is the best known endocrine marker for spermatogenesis. Inhibin B estimation may prove an alternative for testicular biopsy in the differentiation between normal and impaired spermatogenesis.
|
Acknowledgments |
|---|
Received March 23, 1998.
Revised May 14, 1998.
Accepted June 8, 1998.
|
References |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  T.M. Stewart, D.Y. Liu, C. Garrett, N. Jorgensen, E.H. Brown, and H.W.G. Baker Associations between andrological measures, hormones and semen quality in fertile Australian men: inverse relationship between obesity and sperm output Hum. Reprod., July 1, 2009; 24(7): 1561 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Suehiro, E. F. Borba, E. Bonfa, T. S. Okay, M. Cocuzza, P. M. F. Soares, and C. A. A. Silva Testicular Sertoli cell function in male systemic lupus erythematosus Rheumatology, November 1, 2008; 47(11): 1692 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. van Beek, M. Smit, M. M. van den Heuvel-Eibrink, F. H. de Jong, F. G. Hakvoort-Cammel, C. van den Bos, H. van den Berg, R. F.A. Weber, R. Pieters, and S. M.P.F. de Muinck Keizer-Schrama Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood Hum. Reprod., December 1, 2007; 22(12): 3215 - 3222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.A.M. Kuijper, C.B. Lambalk, D.I. Boomsma, S. van der Sluis, M.A. Blankenstein, E.J.C. de Geus, and D. Posthuma Heritability of reproductive hormones in adult male twins Hum. Reprod., August 1, 2007; 22(8): 2153 - 2159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Meeker, L. Godfrey-Bailey, and R. Hauser Relationships Between Serum Hormone Levels and Semen Quality Among Men From an Infertility Clinic J Androl, May 1, 2007; 28(3): 397 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sikaris, R. I. McLachlan, R. Kazlauskas, D. de Kretser, C. A. Holden, and D. J. Handelsman Reproductive Hormone Reference Intervals for Healthy Fertile Young Men: Evaluation of Automated Platform Assays J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5928 - 5936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.M. Mabeck, M.S. Jensen, G. Toft, M. Thulstrup, M. Andersson, T.K. Jensen, A. Giwercman, J. Olsen, J.P. Bonde, and and The Danish First Pregnancy Planners Study Team Fecundability according to male serum inhibin B--a prospective study among first pregnancy planners Hum. Reprod., October 1, 2005; 20(10): 2909 - 2915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fujita, A. Tsujimura, T. Takao, Y. Miyagawa, K. Matsumiya, M. Koga, M. Takeyama, H. Fujioka, K. Aozasa, and A. Okuyama Expression of inhibin {alpha}, glial cell line-derived neurotrophic factor and stem cell factor in Sertoli cell-only syndrome: relation to successful sperm retrieval by microdissection testicular sperm extraction Hum. Reprod., August 1, 2005; 20(8): 2289 - 2294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Andersson, J. H. Petersen, N. Jorgensen, T. K. Jensen, and N. E. Skakkebaek Serum Inhibin B and Follicle-Stimulating Hormone Levels as Tools in the Evaluation of Infertile Men: Significance of Adequate Reference Values from Proven Fertile Men J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2873 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.M. Robertson, T. Stephenson, and R.I. McLachlan Characterization of plasma inhibin forms in fertile and infertile men Hum. Reprod., May 1, 2003; 18(5): 1047 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ramaswamy, G. R. Marshall, C. R. Pohl, R. L. Friedman, and T. M. Plant Inhibitory and Stimulatory Regulation of Testicular Inhibin B Secretion by Luteinizing Hormone and Follicle-Stimulating Hormone, Respectively, in the Rhesus Monkey (Macaca mulatta) Endocrinology, April 1, 2003; 144(4): 1175 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Mahmoud, S. Goemaere, Y. El-Garem, I. Van Pottelbergh, F. H. Comhaire, and J. M. Kaufman Testicular Volume in Relation to Hormonal Indices of Gonadal Function in Community-Dwelling Elderly Men J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 179 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kamischke, A. Baumgardt, J. Horst, and E. Nieschlag Clinical and Diagnostic Features of Patients With Suspected Klinefelter Syndrome J Androl, January 1, 2003; 24(1): 41 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Marchetti, M. Hamdane, V. Mitchell, K. Mayo, L. Devisme, J.M. Rigot, J.C. Beauvillain, E. Hermand, and A. Defossez Immunolocalization of Inhibin and Activin {alpha} and {beta}B Subunits and Expression of Corresponding Messenger RNAs in the Human Adult Testis Biol Reprod, January 1, 2003; 68(1): 230 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. F. E. Garem, A. F. E. Arini, A. H. E. Beheiry, S. A. A. Zeid, and F. H. Comhaire Possible Relationship Between Seminal Plasma Inhibin B and Spermatogenesis in Patients With Azoospermia J Androl, November 1, 2002; 23(6): 825 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vernaeve, H. Tournaye, J. Schiettecatte, G. Verheyen, A.V. Steirteghem, and P. Devroey Serum inhibin B cannot predict testicular sperm retrieval in patients with non-obstructive azoospermia Hum. Reprod., April 1, 2002; 17(4): 971 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. de Rooij, H. J.G. van de Kant, R. Dol, G. Wagemaker, P. P.W. van Buul, A. van Duijn-Goedhart, F. H. de Jong, and J. J. Broerse Long-Term Effects of Irradiation Before Adulthood on Reproductive Function in the Male Rhesus Monkey Biol Reprod, February 1, 2002; 66(2): 486 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujisawa, M. Dobashi, T. Yamasaki, M. Kanzaki, H. Okada, S. Arakawa, and S. Kamidono Significance of serum inhibin B concentration for evaluating improvement in spermatogenesis after varicocelectomy Hum. Reprod., September 1, 2001; 16(9): 1945 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Lee, M. T. Coughlin, and M. F. Bellinger Inhibin B: Comparison with Indexes of Fertility among Formerly Cryptorchid and Control Men J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2576 - 2584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Anniballo, F. Ubaldi, L. Cobellis, M. Sorrentino, L. Rienzi, E. Greco, and J. Tesarik Criteria predicting the absence of spermatozoa in the Sertoli cell-only syndrome can be used to improve success rates of sperm retrieval Hum. Reprod., November 1, 2000; 15(11): 2269 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Ballesca, J. Balasch, J. M Calafell, R. Alvarez, F. Fabregues, M J. M. de Osaba, C. Ascaso, and J. A. Vanrell Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia Hum. Reprod., August 1, 2000; 15(8): 1734 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Winters and T. M. Plant Partial Characterization of Circulating Inhibin-B and Pro-{alpha}C During Development in the Male Rhesus Monkey Endocrinology, December 1, 1999; 140(12): 5497 - 5504. [Abstract] [Full Text]
|
|
|
|
|
|
S. von Eckardstein, M. Simoni, M. Bergmann, G. F. Weinbauer, P. Gassner, A. G. Schepers, and E. Nieschlag Serum Inhibin B in Combination with Serum Follicle-Stimulating Hormone (FSH) Is a More Sensitive Marker Than Serum FSH Alone for Impaired Spermatogenesis in Men, But Cannot Predict the Presence of Sperm in Testicular Tissue Samples J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2496 - 2501. [Abstract] [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
0.01).
